Glycemia Reduction in Type 2 Diabetes - Microvascular and Cardiovascular Outcomes.
GRADE Study Research Group; Nathan DM, Lachin JM, Bebu I, Burch HB, Buse JB, Cherrington AL, Fortmann SP, Green JB, Kahn SE, Kirkman MS, Krause-Steinrauf H, Larkin ME, Phillips LS, Pop-Busui R, Steffes M, Tiktin M, Tripputi M, Wexler DJ, Younes N.
N Engl J Med. 2022 Sep 22;387(12):1075-1088. doi: 10.1056/NEJMoa2200436.
PMID:36129997
Cardiac Autonomic Neuropathy in Diabetes Mellitus.
Agashe S, Petak S.
Methodist Debakey Cardiovasc J. 2018 Oct-Dec;14(4):251-256. doi: 10.14797/mdcj-14-4-251.
PMID:30788010
Approach to the Patient with MODY-Monogenic Diabetes.
Broome DT, Pantalone KM, Kashyap SR, Philipson LH.
J Clin Endocrinol Metab. 2021 Jan 1;106(1):237-250. doi: 10.1210/clinem/dgaa710.
PMID:33034350
Diabetic microvascular complications are associated with left atrial structural alterations in asymptomatic type 2 diabetes patients: A cross-sectional study.
Understanding the drivers and consequences of early-onset type 2 diabetes.
Lim LL, Jones S, Cikomola JC, Hivert MF, Misra S.
Lancet. 2025 Jun 28;405(10497):2327-2340. doi: 10.1016/S0140-6736(25)01012-8. Epub 2025 Jun 23.
PMID:40570863
Mesenchymal Stem Cell Exosomes as a New Strategy for the Treatment of Diabetes Complications.
Xiong J, Hu H, Guo R, Wang H, Jiang H.
Front Endocrinol (Lausanne). 2021 Apr 29;12:646233. doi: 10.3389/fendo.2021.646233. eCollection 2021.
PMID:33995278
Association of ultraprocessed food consumption with risk of microvascular complications among individuals with type 2 diabetes in the UK Biobank: a prospective cohort study.
Li Y, Lai Y, Geng T, Zhang YB, Xia PF, Chen JX, Yang K, Zhou XT, Liao YF, Franco OH, Liu G, Pan A.